Clinical Trial Update: A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Fluticasone Furoate/Vilanterol Inhalation Powder with usual ICS/LABA in persistent asthma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone furoate/vilanterol inhalation powder (fluticasone furoate/vilanterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2019-01-14